Evolution of endpoints for renal transplant outcome (Q35177426)

6 August 2017

1 reference

title

Evolution of endpoints for renal transplant outcome (English)

1 reference

6 August 2017

Sundaram Hariharan

1

1 reference

6 August 2017

Maureen A McBride

series ordinal

2

1 reference

6 August 2017

Eric P Cohen

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

American Journal of Transplantation

6 August 2017

1 reference

6 August 2017

3

1 reference

6 August 2017

8

1 reference

6 August 2017

933-941

1 reference

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Daclizumab to prevent acute rejection in renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Post-transplant renal function in the first year predicts long-term kidney transplant survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Serum cystatin C in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Subclinical rejection in tacrolimus-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Effect of histological damage on long-term kidney transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Risk factors for renal allograft survival from older cadaver donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Improved graft survival after renal transplantation in the United States, 1988 to 1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Chronic rejection in kidney transplants. An in-depth review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Computerized histomorphometric assessment of protocol renal transplant biopsy specimens for surrogate markers of chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

PROTOCOL RENAL ALLOGRAFT BIOPSIES AND THE DESIGN OF CLINICAL TRIALS AIMED TO PREVENT OR TREAT CHRONIC ALLOGRAFT NEPHROPATHY1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

7 January 2021

Cyclosporine: Five Years' Experience in Cadaveric Renal Transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

7 January 2021

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

7 January 2021

Creatinine reduction ratio and 24-hour creatinine excretion on posttransplant day two: simple and objective tools to define graft function.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

7 January 2021

Comparing methods for monitoring serum creatinine to predict late renal allograft failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

7 January 2021

Long-term kidney transplant survival

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00176.X

7 January 2021

10.1034/J.1600-6143.2003.00176.X

Identifiers

DOI

1 reference

6 August 2017

1 reference